COVID-19 vaccination fact sheet (August 3, 2021)
This scientifically accurate and well-cited guide to COVID-19 vaccination is written in lay language, and was developed for a client to distribute to vaccine hesitant staff in their workplace, once the Delta variant began to spread in the United States.
Ending the HIV Epidemic: California Consortium
Developed for CDC on behalf of the California Department of Public Health and health department staff of Alameda, Orange, Riverside, Sacramento, San Bernardino, and San Diego counties, in response to CDC PS 19-1906, calling for 5-year plans to end the HIV epidemic in high-impact jurisdictions.
Ending the Epidemics: Collective Strategies for Addressing HIV, Hepatitis C, and Sexually Transmitted Infections in San Francisco
This plan was written by Facente Consulting over a one-year period, with the input of stakeholders from the San Francisco Department of Public Health, local community organizations, and most importantly members of communities highly impacted by these epidemics in San Francisco.
End Hep C SF Strategic Plan, 2020-2022
Developed for San Francisco's collective impact initiative to eliminate hepatitis C as a public health threat, End Hep C SF.
Issue Brief: Addiction & Recovery
This issue brief was commissioned by Battery Powered, the social engagement "giving program" within San Francisco's social club The Battery. Issue briefs are created once per quarter to educate members on critical societal issues, to help guide foundational giving and improve their community.
San Francisco AIDS Foundation Strategic Plan, 2019-2024
This document is the public summary of the more comprehensive strategic plan developed by Facente Consulting for the San Francisco AIDS Foundation during a year-long process.
2019 Community Health Needs Assessment: San Francisco Campus for Jewish Living
This Community Health Needs Assessment (CHNA) was prepared by Facente Consulting as part of the tri-annual CHNA requirement for this non-profit offering residential medical services for older adults in San Francisco.
Meeting Report: WHO Working Group on HIV Incidence Measurement and Data Use
This report is a summary of the World Health Organization/UNAIDS convening of the international Working Group on HIV Incidence, held in Boston, MA in 2018. Shelley Facente served as WHO's official rapporteur for the meeting and developed this report.
Laying a Foundation for Getting to Zero: California's Integrated HIV Surveillance, Prevention, and Care Plan
Developed for the California Department of Public Health, this plan was released in September 2016 and has been the guiding force for the State of California's quest to "Get to Zero" with HIV.
Treasure Island Children and Youth Needs Assessment
Prepared for the Treasure Island Homeless Development Initiative (now One Treasure Island) and the Treasure Island Development Authority (TIDA), this report provided guidance for the protection of young people already living on Treasure Island in San Francisco during its $1.6 billion redevelopment.
Oakland Transitional Grant Area (TGA) 2015 HIV/AIDS Needs Assessment
Developed for the Oakland TGA Collaborative Community Planning Council, in response to three questions of focus for HIV planning in Alameda and Contra Costa Counties, CA.
Report of an Assessment of Community Perspectives About the Protection of Vulnerable Populations During a Heat Emergency in San Francisco
Developed for the San Francisco Department of Public Health, Environmental Health Branch, to help San Francisco prepare for heat emergencies as a result of global warming.

COVID-19 Data Workshop
Created in partnership with Garrow Consulting LLC, this is a self-directed presentation adapted from a data workshop commissioned by the city of Palm Springs, CA to help people better understand the flood of information out there about COVID-19.
Assocation Between Public Injection and Syringe Sharing Frequency in a Cohort of People Who Inject Drugs in San Francisco and Los Angeles
Meeting of the College on Problems of Drug Dependence (CPDD) - Virtual - June 2020
Interpreting HIV Diagnostic Histories into HIV Infection Date Estimates: An Online Tool
International AIDS Conference - Amsterdam, The Netherlands - July 2018
Estimated Hepatitis C Prevalence and Key Population Sizes in San Francisco: A Foundation for Elimination
9th IAS Conference on HIV Science (HIV/HCV Co-Infection Pre-conference) - Paris, France - July 2017
H1N1 Swine Flu Automated Presentation
Created for the Infectious Disease Emergency Unit, Communicable Disease Control and Prevention Section of the San Francisco Department of Public Health - January 2010
Translation Isn’t Just About Foreign Language: Bridging the Language Gap with HIV Testing
CDC/APHL HIV Diagnostics Conference - Orlando, FL - March 2010

Psychosocial determinants of HIV stigma among men who have sex with men in San Francisco, CA
Bhatta DN, Hecht J, Facente SN. International Journal of Environmental Research and Public Health. 2021; 18(5):8031.
Bovine ownership and reduced pulmonary tuberculosis risk in Nepal: A case–control study
Bates MN, Pope K, Sijali TR, Albers AE, Verma SC. Zoonoses Public Health. 2021; 00:1-8.
Piloting an integrated SARS-CoV-2 testing and data system for outbreak containment among college students: A prospective cohort study
Packel L, Reingold A, Hunter L, Facente SN, Li Y, Harte A, Nicolette G, Urnov FD, Lu M, Petersen M. PLoS ONE. 2021; 16(1): e0245765.
Estimated Dates of Detectable Infection (EDDIs) as an Improvement upon Fiebig Staging for HIV Infection Dating
Facente SN, Grebe E, Pilcher CD, Busch MP, Murphy G, Welte A. Epidemiology & Infection. 2020; 148: e53.
Smoking-Cessation Interventions in Appalachia: A Systematic Review and Meta-Analysis
Gupta S, Scheuter C, Kundu A, Bhat N, Cohen A, Facente SN. American Journal of Preventive Medicine. 2020; 58(2): 261-269.
Interpreting HIV Diagnostic Histories into Infection Time Estimates: Analytical Framework and Online Tool
Grebe E, Facente SN, Bingham J, Pilcher CD, Powrie A, Gerber J, Priede G, Chibawara T, Busch MP, Murphy G, Kassanjee R, Welte, A, and the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). BMC Infectious Diseases. October 26, 2019, 18(894).
Challenges to the Performance of Current HIV Diagnostic Assays and the Need for Centralized Specimen Archives: a Review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) Repository
Facente SN, Busch MP, Grebe E, Pilcher CD, Welte A, Rice B, Murphy G. Gates Open Research. July 23, 2019, 3(1511). doi: https:// doi.org/10.12688/gatesopenres.13048.1.
Performance Comparison of the Maxim and Sedia Limiting Antigen Avidity Assays for Incidence Surveillance
Sempa JB Welte A, Busch MP, Hall J, Hampton D, Keating SM, Facente SN, Marson K, Parkin N, Pilcher CD, Murphy G, Grebe E; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Plos ONE. July 26, 2019, 14(7): e0220345.
Household Fuel Use and Latent Tuberculosis Infection in a Nepali Population
Albers AE, Pope K, Sijali TR, Subramanya SH, Verma SC, Bates MC. Environmental Research. June 2019, 173: 69-76.
A Generalizable Method for Estimating Duration of HIV Infections Using Clinical Testing History and HIV Results
Pilcher CD, Porco TC, Facente SN, Grebe E, Delaney KP, Masciotra S, Kassanjee R, Busch MP, Murphy G, Owen SW, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). AIDS. June 1, 2019, 33(7): 1231-1240.
The Genetic Interaction between HIV and the Antibody Repertoire
Strauli N, Fryer EK, Pham O, Abdel-Mohsen M, Facente SN, Pilcher C, Pennings P, Pillai S, Hernandez RD. The genetic interaction between HIV and the antibody repertoire. bioRxiv. May 23, 2019. doi:10.1101/646968.
New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care
Facente SN, Burk K, Eagen K, Mara ES, Smith AA, Lynch CS. Infectious Disease Clinics of North America. June 2018, 32(2): 313-322.
Localized US Efforts to Eliminate Hepatitis C
Gaudino A, Gay B, Garmon C, Selick M, Vreeland R, Burk K, Huriaux E, Facente SN, Luetkemeyer A, Waters P, Graham CS. Infectious Disease Clinics of North America. June 2018, 32(2): 293-311.
Estimated Hepatitis C Prevalence and Key Population Sizes in San Francisco: A Foundation for Elimination
Facente SN, Grebe E, Burk K., Morris MD, Murphy E, Mirzazadeh A, Smith A, Sanchez M, Evans J, Nishimura A, Raymond HF. PLoS One. April 11, 2018, 13(4): e0195575.
Computational Analysis of Antibody Dynamics Identifies Recent HIV-1 Infection
Seaton KE, Vandergrift NA, Deal AW, Rountree W, Bainbridge J, Grebe E, Anderson DA, Sawant S, Shen X, Yates NL, Denny TN, Liao H-X, Haynes BF, Robb ML, Parkin N, Santon BR, Garrett N, Price MA, Naniche D, Duerr AC, Keating S, Hampton D, Facente S, Marson K, Welte A, Pilcher CD, Cohen MS, Tomaras GD. JCI Insight, December 22, 2017; 2(24): e94355.
Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms
Grebe E, Welte A, Hall J, Keating SM, Facente SN, Marson K, Martin JN, Little SJ, Price MA, Kallas EG, Busch MP, Pilcher CD, Murphy G; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). J Acquir Immune Defic Syndr, December 15, 2017; 76(5):547-555.
HIV Antibody Level as a Marker of HIV Persistence and Low Level Viral Replication
Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP. Journal of Infectious Diseases. 2017, 216:72–81.
Comparison of Cross-sectional HIV Incidence Assay Results from Dried Blood Spots and Plasma
Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O. PLoS One, February 23, 2017, 12(2):e0172283.
Moving Towards a Reliable HIV Incidence Test – Current Status, Resources Available, Future Directions and Challenges Ahead
Murphy G, Pilcher CD, Keating SM, Kassanjee R, Facente SN, Welte A, Grebe E, Marson K, Busch MP, Dailey P, Parkin N, Osborn J, Ongarello S, Marsh K, Garcia-Calleja JM; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA), Foundation for Innovative New Diagnostics, UNAIDS, and the WHO Technical Working Group. Epidemiology & Infection, 2017 Apr, 145(5): 925-941.
Performance of the Bio-Rad Geenius HIV-1/2 Supplemental Assay in Detecting ‘Recent’ HIV Infection and Calculating Population Incidence
Keating SM, Kassanjee R, Lebedeva M, Facente SN, MacArthur JC, Grebe E, Murphy G, Welte A, Martin JN, Little S, Price MA, Kallas EG, Busch MP, Pilcher CD; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). J Acquir Immune Defic Syndr, December 15, 2016, 73(5): 581-588.
Viral Load Criteria and Threshold Optimization to Improve HIV Incidence Assay Characteristics – a CEPHIA Analysis
Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, McKinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). AIDS, 2016, 30:2361-2371.
Using a Multitest Algorithm to Improve the Positive Predictive Value of Rapid HIV Testing and Linkage to HIV Care in Nonclinical HIV Test Sites
Delaney KP, Rurangirwa J, Facente S, Dowling T, Janson M, Knoble T, Vu A, Hu YW, Kerndt PR, King J, Scheer S. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):78-86.
Independent Assessment of Candidate HIV Incidence Assays on Specimens in the CEPHIA Repository
Kassanjee R, Pilcher CD, Keating SM, Facente SN, McKinney E, Price MA, Martin JN, Little S, Hecht FM, Kallas EG, Welte A, Busch MP, and Murphy G. AIDS, October 23, 2014, 28(16): 2439-2449.
Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco
Pilcher CD, Louie B, Facente S, Keating S, Hackett J, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW. PLoS ONE, December 2013, 8(12): e80629. doi:10.1371/journal.pone.0080629.
Performance of Risk-Based Criteria for Targeting Acute HIV Screening in San Francisco
Facente, SN, Pilcher, CD, Hartogensis, WE, Klausner, JD, Philip, SS, Louie, B, Christopoulos, KA, Dowling T, and Colfax GN. PLoS ONE, July 2011, 6(7): e21813. doi:10.1371/journal.pone.0021813
From Questionnaire to Conversation: A Structural Intervention to Improve HIV Test Counseling
Sheon N, Lee S-H, and Facente SN. Patient Education and Counseling, December 2010, 81(3): 468-475.
False Positive Rate of Rapid Oral Fluid HIV Tests Increases as Kits Near Expiration Date
Facente, SN, Dowling, T, Vittinghoff, E, Sykes, DL, and Colfax, GN. PLoS ONE, December 2009, 4(12): e8217. doi:10.1371/journal.pone.0008217. PLoS ONE, December 2009, 4(12): e8217. doi:10.1371/journal.pone.0008217
Addressing Food Security Through Public Policy Action in a Community-Based Participatory Research Partnership
Breckwich-Vásquez, V, Lanza, D, Hennessey-Lavery, S, Facente, S, Halpin, HA, and Minkler, M. Health Promotion Practice, October 2007, 8(4): 342-349.
Sowing the Seeds for Sustainable Change: A Community-Based Participatory Research Partnership for Health Promotion in Indiana, USA and its Aftermath
Minkler, M, Breckwich-Vásquez, V, Rains-Warner, J, Steussey, H, Facente, SN. Health Promotion International, December 2006, 21(4): 293-300.
Post-marketing Surveillance of OraQuick Whole Blood and Oral Fluid Rapid HIV Testing
Wesolowski, LG, MacKellar, DA, Facente, SN, Dowling, T, Ethridge, SF, Zho, JH, and Sullivan, PS. AIDS, August 2006, 20(12):1661-1666.

Contact

415-999-1310
info@facenteconsulting.com

Testimonials

"We sincerely appreciate your efficient, gracious customer service and the level of detail and accountability you have demonstrated during this project. We will most definitely recommend your services to other agencies and contacts. Our team could not be more satisfied with your work, and we look forward to working with you again in the future."

—Jessica L. Fleming, MPH, Cities Readiness Initiative Program Manager, Marion County Public Health Department, Indiana
"I had such a good time working with Facente Consulting and am so appreciative of the theory of change and the report from our retreat. The theory of change has created such simple language for me to use when discussing the program - within 3 months I have already incorporated it into a report and a proposal."

—Zach Ford, Senior Program Manager, AIDS United
"Autumn delivered exceptional work! She was extraordinarily communicative and professional."

—Ryan Anson, NP, East Bay AIDS Center (EBAC)
"Thank you so much for your expansive and grounded thinking as you guided us through this process. At that early meeting, where we were just writing all kinds of ideas and visions down, everything seemed incredibly scattered and chaotic - it made my brain hurt. You took your time to carefully assemble all these seemingly random thoughts and dreams into actual categories and suddenly I could see what was happening. It's almost like you tricked us into creating a strategic plan! I learned a great deal from this process."

—Esther Landau, The Arc San Francisco
"Your revised Ending the Epidemics draft is just brilliant. You set the bar high and always exceed it."

—Mike Shriver, Co-Chair of the San Francisco HIV Community Planning Council
"Shelley — You are a marvelous writer. This project makes me want to get you to evaluate everything we do!"

—Kate Monico Klein, Director, Forensic AIDS Project / San Francisco Department of Public Health, Jail Health Services

Reports and Plans

Presentations and Posters

Peer-Reviewed Articles

Contact

Testimonials

Photography by: Deb Westergaard Photography